z-logo
Premium
The effect of sevoflurane on cerebral blood flow velocity in children
Author(s) -
Fairgrieve R.,
Rowney D. A.,
Karsli C.,
Bissonnette B.
Publication year - 2003
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1046/j.1399-6576.2003.00248.x
Subject(s) - sevoflurane , normocapnia , medicine , anesthesia , transcranial doppler , middle cerebral artery , cerebral blood flow , blood flow , hemodynamics , hypercapnia , ischemia , acidosis
Background:  Sevoflurane is a suitable agent for neuroanesthesia in adult patients. In children, cerebrovascular carbon dioxide reactivity is maintained during hypo‐ and normocapnia under sevoflurane anesthesia. To determine the effects of sevoflurane on middle cerebral artery blood flow velocity (Vmca) in neurologically normal children, Vmca was measured both at different MAC values and at one MAC over a specified time period, using transcranial Doppler sonography. Methods:  Twenty‐six healthy children undergoing elective urological surgery were enrolled (16 patients in part I and 10 in part II). In part I of the study anesthesia comprised sevoflurane 0.5, 1.0 and 1.5 MAC in 30% oxygen and a caudal epidural block. Once steady state had been reached at each sevoflurane MAC level, three measurements of Vmca, mean arterial pressure (MAP) and heart rate (HR) were recorded. In part II of the study patients received sevoflurane 1.0 MAC over a 90‐min period, with the same variables being recorded at 15‐min intervals. Results:  Vmca did not vary significantly at 0.5, 1.0 and 1.5 MAC sevoflurane. There was a significant decrease in MAP between 0.5 MAC and 1.0 MAC sevoflurane ( P <  0.005) and also between 1.0 MAC and 1.5 MAC ( P <  0.01). There was no significant change in Vmca over 90 min at 1.0 MAC sevoflurane. Conclusion:  Sevoflurane does not significantly affect cerebral blood flow velocity in healthy children at working concentrations.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here